PCR Systems, H1N1 Products Drive Q4, Full-Year Growth in Life Tech's Molecular Bio Business

Life Tech's sample prep and PCR products for H1N1 testing contributed approximately $15 million in revenue for the fourth quarter and about $45 million for the full year. The company also saw "continued strength in the TaqMan array business, in addition to strong demand for qPCR instrumentation and reagents."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.